Bixiye
QP51-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2025
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 101 - 110 ee natiijooyinka 3159
Bixiye
QP50-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Bixiye
QP49-25 MHCP Pharmacy Benefit Exclusion for Imaavy™, Lutrate Depot®, Tepylute, Ustekinumab and Ustekinumab-aekn
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Bixiye
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Bixiye
QP47-25 Updated Accessibility Requirements
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Macluumaadka Maaliyadda
Bixiye
Medicaid Reimbursement Policy Cellular and Gene Therapy Products
Macluumaadka Maaliyadda
Bixiye
Commercial Reimbursement Policy Cellular and Gene Therapy Products
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.
Sheegashooyinka iyo Racfaanada
Blue Cross and Blue Shield of Minnesota Self-Insured Complaint Form
Sheegashooyinka iyo Racfaanada
BCBS Fully Insured Complaint Form